GlassScriptPhysician profile
Craig Thieling
NPI 1952409609
$5,267.81
in general payments reported to CMS, 2019-2025
29 companies · $425 in 2025
The $425 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $756 · 2020: $285 · 2021: $1,631 · 2022: $1,126 · 2023: $481 · 2024: $564 · 2025: $425.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,471.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,470.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $1,323.89 | 2019-2024 | Impella |
| Boston Scientific Corporation | $1,197.08 | 2019-2025 | Ranger, Watchman Access System, Farapulse |
| Novartis Pharmaceuticals Corporation | $852.71 | 2019-2025 | |
| Inari Medical, INC. | $502.07 | 2020-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic, INC. | $146.61 | 2021-2025 | Linq II, Corevalve Evolut R, Symplicity G3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $113.73 | 2021-2025 | Jardiance |
| Shockwave Medical, INC | $108.47 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Chiesi USA, INC. | $98.08 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $85.54 | 2021-2022 | |
| Edwards Lifesciences Corporation | $80.91 | 2022-2025 | Sapien 3 Ultra Resilia, Pascal |
| Philips North America LLC | $79.79 | 2019 | |
| Pfizer INC. | $76.27 | 2019-2022 | |
| Medtronic Vascular, INC. | $72.12 | 2019-2020 | |
| Atricure, INC. | $67.73 | 2021-2023 | |
| Abbott Laboratories | $63.24 | 2019-2023 | Diamondback Peripheral, Perclose Prostyle |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $63.03 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $45.44 | 2023-2025 | Eliquis |
| Janssen Pharmaceuticals, INC | $42.54 | 2022-2024 | Xarelto |
| Biosense Webster, INC. | $37.13 | 2023-2025 | Carto 3 |
| Bayer Healthcare Pharmaceuticals INC. | $36.85 | 2021-2025 | |
| Amgen INC. | $32.44 | 2019-2022 | |
| Astellas Pharma US INC | $22.75 | 2021 | |
| Cardiva Medical, INC. | $21.84 | 2024 | Savvywire |
| Recor Medical INC | $21.06 | 2024 | Paradise Renal Denervation System |
| Bracco Diagnostics INC. | $20.07 | 2022 | |
| Stryker Corporation | $16.09 | 2025 | Artix Mt |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.17 | 2025 | Lifevest |
| Gilead Sciences, INC. | $13.19 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $11.97 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Thieling listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.